Published in Women's Health Weekly, June 28th, 2001
"Because female sex protects against dyslipidemia and atherosclerosis in normal subjects, we aimed to reveal potential sex differences in metabolic side effects of a newly initiated highly active antiretroviral therapy (HAART) regimen," explained P. Quehenberger and colleagues at the University of Vienna.
Female patients' natural defenses against abnormally high lipid levels do not protect them from HAART-induced dyslipidemia and other metabolic alterations,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.